Trimarchi Thomas
BridgeBio Pharma, Inc. - Common Stock · President and CFO
Trimarchi Thomas is listed in filings as President and CFO at BridgeBio Pharma, Inc. - Common Stock. This profile follows SEC Form 4 activity through May 19, 2026, including sale activity. Recent filings connect the profile to BridgeBio Pharma, Inc. - Common Stock (BBIO). The current snapshot covers public activity from Mar 21, 2025 to May 19, 2026. Reported amounts are shown as $721.4K to $771.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $101k2k shares | SellAug 18, 2025 | $50.94 | $67.37 | |
| $771k15.4k shares | SellAug 18, 2025 | $50.14 | $67.37 | |
| $2.1M42.2k shares | SellAug 21, 2025 | $49.48 | $67.37 | |
| $465k7k shares | SellNov 17, 2025 | $66.84 | $67.37 | |
| $660k10k shares | SellNov 17, 2025 | $66.19 | $67.37 | |
| $15k200 shares | SellFeb 17, 2026 | $75.38 | $67.37 | |
| $1.0M13.4k shares | SellFeb 17, 2026 | $74.71 | $67.37 |